Ma H - Search Results

1

Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): a case-control study in eastern Chinese populations.

Hu H, Yang J, Sun Y, Yang Y, Qian J, Jin L, Wang M, Bi R, Zhang R, Zhu M, Sun M, Ma H, Wei Q, Jiang G, Zhou X, Chen H. Hu H, et al. Among authors: ma h. Ann Surg Oncol. 2012 Jul;19(7):2403-10. doi: 10.1245/s10434-011-2160-y. Epub 2011 Dec 28. Ann Surg Oncol. 2012. PMID: 22203178

2

Dinucleotide polymorphism of p73 gene is associated with a reduced risk of lung cancer in a Chinese population.

Hu Z, Miao X, Ma H, Tan W, Wang X, Lu D, Wei Q, Lin D, Shen H. Hu Z, et al. Among authors: ma h. Int J Cancer. 2005 Apr 10;114(3):455-60. doi: 10.1002/ijc.20746. Int J Cancer. 2005. PMID: 15578704

3

A promoter polymorphism (-77T>C) of DNA repair gene XRCC1 is associated with risk of lung cancer in relation to tobacco smoking.

Hu Z, Ma H, Lu D, Zhou J, Chen Y, Xu L, Zhu J, Huo X, Qian J, Wei Q, Shen H. Hu Z, et al. Among authors: ma h. Pharmacogenet Genomics. 2005 Jul;15(7):457-63. doi: 10.1097/01.fpc.0000167329.85163.0d. Pharmacogenet Genomics. 2005. PMID: 15970793

4

Allele 2 of the interleukin-1 receptor antagonist gene (IL1RN*2) is associated with a decreased risk of primary lung cancer.

Hu Z, Shao M, Chen Y, Zhou J, Qian J, Xu L, Ma H, Wang X, Xu Y, Lu D, Shen H. Hu Z, et al. Among authors: ma h. Cancer Lett. 2006 May 18;236(2):269-75. doi: 10.1016/j.canlet.2005.05.015. Epub 2005 Jul 14. Cancer Lett. 2006. PMID: 16019127

5

XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies.

Hu Z, Ma H, Chen F, Wei Q, Shen H. Hu Z, et al. Among authors: ma h. Cancer Epidemiol Biomarkers Prev. 2005 Jul;14(7):1810-8. doi: 10.1158/1055-9965.EPI-04-0793. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16030121 Review.

6

Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.

Hu Z, Huo X, Lu D, Qian J, Zhou J, Chen Y, Xu L, Ma H, Zhu J, Wei Q, Shen H. Hu Z, et al. Among authors: ma h. Clin Cancer Res. 2005 Aug 1;11(15):5433-9. doi: 10.1158/1078-0432.CCR-05-0311. Clin Cancer Res. 2005. PMID: 16061858

7

Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population.

Hu Z, Ma H, Lu D, Qian J, Zhou J, Chen Y, Xu L, Wang X, Wei Q, Shen H. Hu Z, et al. Among authors: ma h. Int J Cancer. 2006 Mar 1;118(5):1275-8. doi: 10.1002/ijc.21463. Int J Cancer. 2006. PMID: 16152608

8

Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population.

Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Jin G, Liu J, Wang X, Wei Q, Shen H. Ma H, et al. Cancer Lett. 2006 Aug 28;240(2):261-7. doi: 10.1016/j.canlet.2005.09.019. Epub 2005 Nov 8. Cancer Lett. 2006. PMID: 16288830

9

Joint effects of single nucleotide polymorphisms in P53BP1 and p53 on breast cancer risk in a Chinese population.

Ma H, Hu Z, Zhai X, Wang S, Wang X, Qin J, Chen W, Jin G, Liu J, Gao J, Wang X, Wei Q, Shen H. Ma H, et al. Carcinogenesis. 2006 Apr;27(4):766-71. doi: 10.1093/carcin/bgi295. Epub 2005 Nov 28. Carcinogenesis. 2006. PMID: 16314399

10

Functional variants in the promoter of interleukin-1beta are associated with an increased risk of breast cancer: a case-control analysis in a Chinese population.

Liu J, Zhai X, Jin G, Hu Z, Wang S, Wang X, Qin J, Gao J, Ma H, Wang X, Wei Q, Shen H. Liu J, et al. Among authors: ma h. Int J Cancer. 2006 May 15;118(10):2554-8. doi: 10.1002/ijc.21652. Int J Cancer. 2006. PMID: 16358261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,782 results

Search Page

Filters